CJJD logo

China Jo-Jo Drugstores (CJJD) EBITDA

Annual EBITDA

$1.23 M
+$21.19 M+106.15%

March 31, 2024

Summary

Performance

1-Year Change

+106.15%

3-Year Change

+119.99%

5-Year Change

+148.64%

15-Year Change

+128.92%

CJJD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.73%
CJJD annual EBITDA is higher than 79.73% of companies in Healthcare sector

High & Low

All-time High

$13.16 M
CJJD annual EBITDA is currently -90.68% below its historical high of $13.16 million

3-Year Low

-$19.96 M

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
CJJD previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
CJJD next annual earnings announcement has not yet been scheduled

OtherCJJDprofitabilitymetrics:

Annual Revenue

$154.54 M
CJJD annual revenue is $154.54 million

Annual Net Income

-$4.23 M
CJJD annual net profit is -$4.23 million

Annual EBIT

-$4.16 M
CJJD annual earnings before interest & taxes is -$4.16 million

Annual EPS

-$2.93
CJJD annual earnings per share is -$2.93

Quarterly EBITDA

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CJJD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.84 M
CJJD quarterly EBITDA is currently at an all-time high

3-Year Low

-
CJJD quarterly EBITDA 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CJJD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CJJD next earnings announcement is scheduled for Feb 10, 2025

OtherCJJDprofitabilitymetrics:

Quarterly Revenue

-
CJJD quarterly revenue value is unknown

Quarterly Net Income

-
CJJD quarterly net profit value is unknown

Quarterly EBIT

-
CJJD quarterly earnings before interest & taxes value is unknown

Quarterly EPS

-
CJJD quarterly earnings per share value is unknown

TTM EBITDA

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CJJD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.37 M
CJJD TTM EBITDA is currently at an all-time high

3-Year Low

-
CJJD TTM EBITDA 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CJJD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CJJD next earnings announcement is scheduled for Feb 10, 2025

OtherCJJDprofitabilitymetrics:

TTM Revenue

-
CJJD TTM revenue value is unknown

TTM Net Income

-
CJJD TTM net profit value is unknown

TTM EBIT

-
CJJD TTM earnings before interest & taxes value is unknown

TTM EPS

-
CJJD TTM earnings per share value is unknown

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$1.23 M
CJJD annual EBITDA is $1.23 million

Annual Net Income

-$4.23 M
CJJD annual net profit is -$4.23 million

Annual Interest Expense

$13.60 K
CJJD annual interest expense is $13.60 thousand

Annual Income Tax

$62.90 K
CJJD annual income tax is $62.90 thousand

Annual D&A

$5.38 M
CJJD annual depreciation & amortization is $5.38 million

CJJD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+106.2%--
3 y3 years+120.0%--
5 y5 years+148.6%--

CJJD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+106.2%
5 y5-yearat high+106.2%
alltimeall time-90.7%+106.2%

China Jo-Jo Drugstores EBITDA History

DateAnnualQuarterlyTTM
Mar 2024
$1.23 M(-106.1%)
-
-
Mar 2023
-$19.96 M(+3342.0%)
-
-
Mar 2022
-$579.90 K(-90.6%)
-
-
Mar 2021
-$6.14 M(+67.7%)
$18.90 K(-100.3%)
-$6.14 M(-24.6%)
Dec 2020
-
-$5.78 M(+521.2%)
-$8.14 M(+491.8%)
Sep 2020
-
-$930.90 K(-267.2%)
-$1.38 M(+11.6%)
Jun 2020
-
$556.90 K(-128.1%)
-$1.23 M(-66.3%)
Mar 2020
-$3.66 M(-841.8%)
-$1.98 M(-302.2%)
-$3.66 M(-265.7%)
Dec 2019
-
$979.10 K(-224.2%)
$2.21 M(-527.2%)
Sep 2019
-
-$788.50 K(-57.8%)
-$517.00 K(-53.2%)
Jun 2019
-
-$1.87 M(-148.1%)
-$1.11 M(-324.1%)
Mar 2019
$493.40 K(-103.3%)
$3.89 M(-322.7%)
$493.40 K(-103.5%)
Dec 2018
-
-$1.75 M(+26.8%)
-$14.21 M(+0.2%)
Sep 2018
-
-$1.38 M(+407.0%)
-$14.18 M(+0.2%)
Jun 2018
-
-$271.60 K(-97.5%)
-$14.15 M(-5.6%)
Mar 2018
-$15.05 M(+254.9%)
-$10.82 M(+530.9%)
-$14.99 M(+71.0%)
Dec 2017
-
-$1.71 M(+27.3%)
-$8.76 M(+17.8%)
Sep 2017
-
-$1.35 M(+21.4%)
-$7.44 M(+29.2%)
Jun 2017
-
-$1.11 M(-75.8%)
-$5.76 M(+35.7%)
Mar 2017
-$4.24 M(-296.8%)
-$4.59 M(+1073.4%)
-$4.24 M(-390.1%)
Dec 2016
-
-$391.40 K(-216.5%)
$1.46 M(-12.7%)
Sep 2016
-
$335.90 K(-17.4%)
$1.67 M(+19.5%)
Jun 2016
-
$406.50 K(-63.4%)
$1.40 M(-20.7%)
Mar 2016
$2.16 M(-52.4%)
$1.11 M(-719.7%)
$1.77 M(-53.8%)
Dec 2015
-
-$179.30 K(-387.3%)
$3.82 M(-20.1%)
Sep 2015
-
$62.40 K(-91.9%)
$4.78 M(-6.9%)
Jun 2015
-
$772.50 K(-75.6%)
$5.14 M(+13.5%)
Mar 2015
$4.53 M
$3.17 M(+304.1%)
$4.53 M(-173.3%)
Dec 2014
-
$783.50 K(+88.4%)
-$6.18 M(-59.7%)
DateAnnualQuarterlyTTM
Sep 2014
-
$415.80 K(+155.2%)
-$15.31 M(-2.5%)
Jun 2014
-
$162.90 K(-102.2%)
-$15.70 M(-1.8%)
Mar 2014
-$16.00 M(+62.9%)
-$7.54 M(-9.8%)
-$16.00 M(-7.8%)
Dec 2013
-
-$8.35 M(<-9900.0%)
-$17.35 M(+48.8%)
Sep 2013
-
$28.90 K(-122.0%)
-$11.67 M(+6.0%)
Jun 2013
-
-$131.60 K(-98.5%)
-$11.00 M(+12.0%)
Mar 2013
-$9.82 M(-176.6%)
-$8.90 M(+233.7%)
-$9.82 M(-1042.7%)
Dec 2012
-
-$2.67 M(-484.4%)
$1.04 M(-84.7%)
Sep 2012
-
$693.60 K(-34.0%)
$6.81 M(-26.0%)
Jun 2012
-
$1.05 M(-46.5%)
$9.20 M(-28.3%)
Mar 2012
$12.82 M(+3.5%)
$1.96 M(-36.7%)
$12.82 M(-10.8%)
Dec 2011
-
$3.10 M(+0.5%)
$14.37 M(+0.8%)
Sep 2011
-
$3.08 M(-34.1%)
$14.26 M(+2.6%)
Jun 2011
-
$4.68 M(+33.3%)
$13.90 M(+12.2%)
Mar 2011
$12.39 M(-5.9%)
$3.51 M(+17.5%)
$12.39 M(-9.7%)
Dec 2010
-
$2.99 M(+9.6%)
$13.72 M(-4.0%)
Sep 2010
-
$2.73 M(-13.9%)
$14.29 M(+2.8%)
Jun 2010
-
$3.17 M(-34.6%)
$13.90 M(+29.5%)
Mar 2010
$13.16 M(<-9900.0%)
$4.84 M(+36.3%)
$10.73 M(+82.3%)
Dec 2009
-
$3.55 M(+52.0%)
$5.89 M(+152.8%)
Sep 2009
-
$2.34 M(>+9900.0%)
$2.33 M(<-9900.0%)
Jul 2009
-$9700.00(-66.2%)
$1200.00(-127.9%)
-$9700.00(-34.9%)
Apr 2009
-
-$4300.00(-21.8%)
-$14.90 K(-45.6%)
Jan 2009
-
-$5500.00(+400.0%)
-$27.40 K(-5.5%)
Oct 2008
-
-$1100.00(-72.5%)
-$29.00 K(+0.7%)
Jul 2008
-$28.70 K(+675.7%)
-$4000.00(-76.2%)
-$28.80 K(+16.1%)
Apr 2008
-
-$16.80 K(+136.6%)
-$24.80 K(+210.0%)
Jan 2008
-
-$7100.00(+688.9%)
-$8000.00(+788.9%)
Oct 2007
-
-$900.00
-$900.00
Jul 2007
-$3700.00
-
-

FAQ

  • What is China Jo-Jo Drugstores annual EBITDA?
  • What is the all time high annual EBITDA for China Jo-Jo Drugstores?
  • What is China Jo-Jo Drugstores annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for China Jo-Jo Drugstores?
  • What is the all time high TTM EBITDA for China Jo-Jo Drugstores?

What is China Jo-Jo Drugstores annual EBITDA?

The current annual EBITDA of CJJD is $1.23 M

What is the all time high annual EBITDA for China Jo-Jo Drugstores?

China Jo-Jo Drugstores all-time high annual EBITDA is $13.16 M

What is China Jo-Jo Drugstores annual EBITDA year-on-year change?

Over the past year, CJJD annual EBITDA has changed by +$21.19 M (+106.15%)

What is the all time high quarterly EBITDA for China Jo-Jo Drugstores?

China Jo-Jo Drugstores all-time high quarterly EBITDA is $4.84 M

What is the all time high TTM EBITDA for China Jo-Jo Drugstores?

China Jo-Jo Drugstores all-time high TTM EBITDA is $14.37 M